PKR Protein (Protein Kinase R)

PKR Protein (Protein Kinase R)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PKR Protein (Protein Kinase R)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[EIF2AK2](/genes/eif2ak2)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[P19589](https://www.uniprot.org/uniprot/P19589)</td>
</tr>
<tr>
<td class="label">PDB Structures</td>
<td>2E7O, 3UI8, 5Y36</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~62 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Serine/Threonine Kinase (PKR family)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, high in brain</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td>
</tr>
</table>

PKR Protein (Protein Kinase R)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PKR Protein (Protein Kinase R)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[EIF2AK2](/genes/eif2ak2)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[P19589](https://www.uniprot.org/uniprot/P19589)</td>
</tr>
<tr>
<td class="label">PDB Structures</td>
<td>2E7O, 3UI8, 5Y36</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~62 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Serine/Threonine Kinase (PKR family)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, high in brain</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td>
</tr>
</table>

PKR (Protein Kinase R, also known as EIF2AK2) is a serine/threonine protein kinase that plays a central role in the cellular stress response, particularly in antiviral defense and translational control["@b愛德华茲2020"]. Also known as double-stranded RNA-dependent protein kinase (DSRNA-PK), PKR is activated by various stress signals including viral RNA, cellular stress, and protein aggregates found in neurodegenerative diseases.

In the context of neurodegenerative disorders, PKR has emerged as a key player in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other conditions. The kinase phosphorylates the translation initiation factor eIF2alpha, leading to global protein synthesis inhibition, and is activated by various pathological protein aggregates. Understanding PKR's role may lead to therapeutic strategies for neuroprotection.

Protein Infobox

Structure

PKR contains an N-terminal regulatory domain and a C-terminal kinase domain:

N-terminal Regulatory Domain

• Double-stranded RNA binding domain (DRBD): Binds dsRNA of viral origin
• Zinc finger domain: Involved in protein-protein interactions
• Regulatory motifs: Control kinase activation

C-terminal Kinase Domain

• Kinase subdomain XI: Contains the catalytic site
• Activation loop: Phosphorylation site (Thr446)
• ATP-binding pocket: Target of small molecule inhibitors

Regulatory Mechanisms

• Autophosphorylation: Required for kinase activation
• Dimerization: Induced by dsRNA binding
• Inhibitory proteins: PACT (protein activator of PKR)

Normal Function

Antiviral Defense

dsRNA Detection

• Binds to double-stranded RNA (viral replication intermediate)
• Activation triggers interferon-stimulated genes
• Blocks viral protein synthesis

eIF2α Phosphorylation

• Phosphorylates translation initiation factor eIF2α
• Inhibits global protein synthesis
• Reduces viral replication
• Conserves cellular resources during stress

Integrated Stress Response

• eIF2α phosphorylation is the hallmark of ISR activation
• Four kinases: PKR, PERK, GCN2, HRI
• Common downstream: ATF4-mediated transcription

Translational Control

• Global inhibition: Through eIF2α phosphorylation
• Selective translation: Some mRNAs escape inhibition
• Stress granule formation: mRNA sequestration

Role in Neurodegeneration

Alzheimer's Disease

PKR is implicated in AD through multiple mechanisms[@carroll2018]:

Activation in AD Brain

• PKR is activated in AD hippocampus and frontal cortex
• Activation correlates with disease severity
• Early activation before significant pathology

eIF2α Phosphorylation

• Elevated eIF2α-P in AD brains
• Leads to synaptic protein synthesis inhibition
• Contributes to memory impairment

Links to Aβ and Tau

• [Amyloid-beta](/proteins/amyloid-beta) can activate PKR
• [Tau](/proteins/tau) pathology enhances PKR activation
• Creates a feed-forward loop of neurodegeneration

ER Stress

• ER stress activates PKR
• Contributes to the unfolded protein response
• Leads to apoptosis in vulnerable neurons

Parkinson's Disease

PKR is activated in PD and contributes to dopaminergic neuron death[@sukh2020]:

α-Synuclein Activation

• [Alpha-synuclein](/proteins/alpha-synuclein) aggregates can activate PKR
• Activated PKR in PD substantia nigra
• Contributes to protein synthesis deficits

Mitochondrial Stress

• Mitochondrial toxins activate PKR
• Links mitochondrial dysfunction to translational repression
• Exacerbates energy deficits in dopaminergic neurons

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS)

• PKR activation in motor neurons
• Contributes to translational inhibition
• Mouse models show protection with PKR deletion

Huntington's Disease

• Mutant huntingtin activates PKR
• Contributes to translational dysfunction
• Therapeutic target

Multiple Sclerosis

• PKR in demyelination and neuroinflammation
• Contributes to oligodendrocyte death

Therapeutic Targeting

PKR Inhibitors

Several approaches are being developed[@yoshino2019]:

Small Molecule Inhibitors

• 2-aminopurine: First-generation inhibitor
• C16: More potent and specific
• Imidazoles: Novel inhibitors in development

Challenges

• CNS penetration: Essential for neurodegenerative applications
• Selectivity: Avoiding off-target effects
• Timing: When to intervene in disease course

Alternative Strategies

Reducing PKR Activation

• Targeting upstream activators
• Preventing protein aggregate formation
• Modulating stress responses

ISR Modulation

• Other ISR kinases can compensate
• eIF2α phosphatases as targets
• ATF4 modulators

Gene Therapy

• Reducing PKR expression
• Dominant-negative constructs
• Antisense oligonucleotides

Key Publications

Cross-Links

• [EIF2AK2 Gene](/genes/eif2ak2) - Gene page
• [eIF2α](/proteins/eif2a) - Key substrate
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease
• [Parkinson's Disease](/diseases/parkinsons-disease) - Disease
• [Integrated Stress Response](/mechanisms/integrated-stress-response)
• [Alpha-Synuclein](/proteins/alpha-synuclein) - PD protein

References

See Also

• [EIF2AK2 Gene](/genes/eif2ak2)
• [Integrated Stress Response](/mechanisms/integrated-stress-response)
• [eIF2α Phosphorylation](/mechanisms/eif2-alpha-phosphorylation)
• [Translational Control](/mechanisms/translational-control)
• [ER Stress Response](/mechanisms/er-stress-pathway)
• [Synaptic Protein Synthesis](/mechanisms/synaptic-translation)

External Links

• [UniProt: P19589](https://www.uniprot.org/uniprot/P19589)
• [GeneCards: EIF2AK2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EIF2AK2)
• [PDB: PKR kinase domain](https://www.rcsb.org/structure/2E7O)
• [Kinase database: PKR](https://www.kinase.com/)